ROS1 gene rearrangement, originally described in glioblastomas (FIG‐ROS1) [17], is reported at 2% in NSCLC [2] and up to 3.3% in LUAC [18]. The gene discussed is ROS1; the disease is non-small cell lung carcinoma.